MarketPeel
Insider Trading Intelligence
JT

Jennifer Tousignant

VRDN
CHIEF LEGAL OFFICER · VIRIDIAN THERAPEUTICS, INC.DE · CIK 0002010978
FILING MIX · LIFETIME60%/40%
BUYS
6
SELLS
4
TOTAL VALUE
$171.9K
COMPANIES
1
ACTIVE SINCE
Feb 2024
HOLDINGS NOW
3,494
AVG SELL PX
$30.31
TRADE KIND
SHOWING 10 / 10
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Jennifer Tousignant, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-1.77%+1.12%-2.89%-2.89%
14d1+0.00%+8.55%+1.24%+7.31%+7.31%
30d1+0.00%+6.04%+1.47%+4.57%+4.57%
60d1+100.00%-2.80%+0.65%-3.45%-3.45%
90d1+100.00%-37.15%-4.63%-32.52%-32.52%
180d1+100.00%-42.48%+6.90%-49.38%-49.38%
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
VRDN · 3,494 shares · as of Mar 3, 2026
072,500145,000217,500290,00020252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 6 buys / 4 sellsCOVERAGE · 9 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
VRDN
VIRIDIAN THERAPEUTICS, INC.DE
SALE
Chief Legal Officer
1,724$29.32$50.5K3,445Mar 3, 2026Mar 4, 2026View →
VRDN
VIRIDIAN THERAPEUTICS, INC.DE
SALE
Chief Legal Officer
5,16915,510Mar 3, 2026Mar 4, 2026View →
VRDN
VIRIDIAN THERAPEUTICS, INC.DE
PURCHASE
Chief Legal Officer
5,1695,169Mar 3, 2026Mar 4, 2026View →
VRDN
VIRIDIAN THERAPEUTICS, INC.DE
SALE
Chief Legal Officer
1,675$30.19$50.6K3,494Mar 3, 2026Mar 9, 2026View →
VRDN
VIRIDIAN THERAPEUTICS, INC.DE
PURCHASEGRANT
Stock grant
23,85023,850Mar 2, 2026Mar 4, 2026View →
VRDN
VIRIDIAN THERAPEUTICS, INC.DE
PURCHASEGRANT
Stock grant
119,300119,300Mar 2, 2026Mar 4, 2026View →
VRDN
VIRIDIAN THERAPEUTICS, INC.DE
SALE
Chief Legal Officer
2,272$31.16$70.8K0Dec 31, 2025Jan 2, 2026View →
VRDN
VIRIDIAN THERAPEUTICS, INC.DE
PURCHASEGRANT
Stock grant
20,67920,679Mar 3, 2025Mar 4, 2025View →
VRDN
VIRIDIAN THERAPEUTICS, INC.DE
PURCHASEGRANT
Stock grant
124,072124,072Mar 3, 2025Mar 4, 2025View →
VRDN
VIRIDIAN THERAPEUTICS, INC.DE
PURCHASEGRANT
Stock grant
290,000290,000Feb 12, 2024Feb 14, 2024View →
Other insiders · VRDN
Loading peer insiders…
About this filer
CIK 0002010978
ROLE
Chief Legal Officer
PRIMARY
VRDN
COMPANIES
1
ACTIVE SINCE
Feb 2024
MARKETPEEL · /INSIDER/0002010978DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback